Chemoenzymatic Synthesis: Combining Chemistry and Biology for Drug Discovery

Hanna Reetz^*
*Correspondence: Hanna Reetz, Department of Chemistry and Biochemistry, USA, Email:

Introduction

The process of drug discovery has traditionally relied on organic chemistry to synthesize small molecules that can interact with biological targets to treat diseases. However, as the complexity of diseases and the need for more targeted therapies increase, traditional methods have limitations in terms of selectivity, efficacy, and sustainability. Chemoenzymatic synthesis, which combines the power of organic chemistry and biocatalysis, is emerging as a promising approach to overcome these challenges and enhance drug discovery efforts. Chemoenzymatic synthesis involves using both chemical reactions and enzymatic processes to create complex molecules, offering significant advantages over purely chemical or biological methods. By integrating enzymes, which are highly selective biological catalysts, with traditional chemical synthesis techniques, researchers can streamline the synthesis of bioactive compounds with greater precision and efficiency. Enzymes can catalyze reactions that are often challenging or impossible to achieve using standard chemical methods, such as the formation of stereocenters, chirality, and functional group manipulations. Additionally, enzymes operate under mild conditions (low temperatures, neutral pH), making them more environmentally friendly and compatible with the principles of green chemistry [1].

Description

The synergy between chemistry and biology in chemoenzymatic synthesis enables the creation of complex, biologically active molecules, including natural product analogs, biologics, and drug-like compounds. This combined approach allows for the rapid development of drug candidates with enhanced selectivity, bioavailability, and metabolic stabilityâ??all crucial properties for effective therapeutics. Furthermore, chemoenzymatic synthesis can be applied at various stages of drug development, from lead optimization to the scalable production of therapeutic agents. By leveraging the strengths of both chemistry and biology, chemoenzymatic synthesis opens up new avenues for drug discovery, offering the potential for more efficient, sustainable, and innovative methods for developing novel therapeutics. This approach not only accelerates the creation of drug candidates but also aligns with the growing demand for precision medicine, where treatments are tailored to the specific needs of individual patients. As research continues to advance, chemoenzymatic synthesis is poised to play a pivotal role in the future of medicinal chemistry and drug development. Chemoenzymatic synthesis is an innovative approach that combines the precision of chemical synthesis with the efficiency and selectivity of biocatalysis to create complex bioactive molecules, offering a powerful strategy for drug discovery. In this method, chemical reactions are complemented or enhanced by enzymatic processes, enabling the synthesis of molecules that may be challenging or inefficient to obtain through conventional chemical or biological methods alone. Enzymes, which are highly selective proteins, can catalyze reactions under mild conditions, such as ambient temperature, neutral pH, and low toxicity, which makes them advantageous for producing sensitive or unstable compounds. This contrasts with traditional organic chemistry, which often requires harsh conditions (high temperatures, extreme pH, toxic solvents) that can degrade sensitive intermediates or produce undesirable by-products. As a result, chemoenzymatic synthesis aligns well with green chemistry principles, which emphasize sustainability, environmental friendliness, and minimizing the use of hazardous reagents. One of the key advantages of chemoenzymatic synthesis is its ability to introduce complex stereochemistry a critical feature for drug molecules, as the 3D arrangement of atoms often determines the biological activity of a compound. Enzymes can selectively catalyze stereoselective reactions, making them ideal for the creation of chiral molecules that are often required in drug discovery. The precision of enzymes in recognizing and acting on specific substrates also allows for the regioselectivity (selecting the right position on a molecule to modify) and functional group specificity that would be difficult to achieve with purely synthetic methods. A notable strength of chemoenzymatic synthesis is its ability to functionalize complex natural products. Many drugs, including anticancer agents, antibiotics, and immunosuppressants, are derived from natural products. However, the traditional total synthesis of these complex molecules is often difficult, time-consuming, and inefficient. By incorporating enzymes into the synthesis process, researchers can modify natural products more efficiently, creating synthetic analogs that have improved pharmacological properties or therapeutic efficacy. For example, biotransformation reactions, where enzymes are used to modify a molecule (e.g., oxidation, reduction, hydrolysis), can be integrated with traditional chemical steps to produce new compounds with enhanced properties or reduced toxicity [2].

Conclusion

In conclusion, chemoenzymatic synthesis is a powerful and innovative approach that combines the precision of chemical synthesis with the selectivity of enzymatic catalysis, offering significant advantages for drug discovery and development. By enabling the efficient creation of complex, bioactive molecules under mild conditions, this method enhances stereoselectivity, functional group specificity, and regioselectivity, crucial for developing effective therapeutics. It allows for rapid lead optimization, the modification of natural products, and the scalable production of drug candidates, aligning with green chemistry principles. As advances in enzyme engineering and biocatalysis continue, chemoenzymatic synthesis is set to play a pivotal role in creating safer, more targeted, and more sustainable drugs, revolutionizing the future of medicinal chemistry.

References

1. King-Smith, Emma, Christian R. Zwick III and Hans Renata. "Applications of oxygenases in the chemoenzymatic total synthesis of complex natural products." Biochemistry 57 (2018): 403-412.

Google Scholar, Crossref, Indexed at

2. Johnson, Luke A., Alice Dunbabin, Jennifer CR Benton and Robert J. Mart, et al. "Modular chemoenzymatic synthesis of terpenes and their analogues." Angew Chem Int Ed 59 (2020): 8486-8490.

Google Scholar, Crossref, Indexed at